Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
GOSS on Nasdaq
Shares outstanding
232,945,000
Price per share
$2.55
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
180,653,789
Total reported value
$559,988,381
% of total 13F portfolios
0%
Share change
+1,068,905
Value change
+$5,504,913
Number of holders
191
Price from insider filings
$2.55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Octagon Capital Advisors LP 6.5% -23% $46,938,418 -$13,747,350 15,141,425 -23% Octagon Capital Advisors LP 31 Dec 2025
BlackRock, Inc. 6.5% +24% $46,705,201 +$9,084,437 15,065,708 +24% BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 5% +15% $14,035,274 +$1,693,271 11,410,792 +14% The Vanguard Group 30 Jun 2025
Invus Global Management, LLC 2.8% $5,507,814 6,258,880 Invus Public Equities, L.P. 31 Dec 2024

As of 31 Dec 2025, 191 institutional investors reported holding 180,653,789 shares of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS). This represents 78% of the company’s total 232,945,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 7.8% 18,093,034 0% 2.9% $56,088,405
BlackRock, Inc. 7.3% 17,056,878 +23% 0% $52,876,322
Octagon Capital Advisors LP 6% 13,915,371 -18% 5.4% $43,137,650
VANGUARD GROUP INC 5.5% 12,873,209 +7.2% 0% $39,906,948
STATE STREET CORP 4% 9,310,969 +140% 0% $28,864,004
ARCH Venture Management, LLC 3.5% 8,055,916 0% 3.8% $24,973,340
SAMSARA BIOCAPITAL, LLC 3.1% 7,222,559 +18% 2.3% $22,389,933
Siren, L.L.C. 2.2% 5,208,968 0% 0.48% $16,147,801
683 Capital Management, LLC 2.2% 5,190,800 +2.6% 1.3% $16,091,480
HHLR ADVISORS, LTD. 2.1% 4,974,041 0% 0.5% $15,419,527
GEODE CAPITAL MANAGEMENT, LLC 2.1% 4,872,714 +3.9% 0% $15,109,345
Palo Alto Investors LP 1.9% 4,471,592 -18% 1.9% $13,861,935
ACADIAN ASSET MANAGEMENT LLC 1.9% 4,416,903 -12% 0.02% $13,687,000
FMR LLC 1.8% 4,237,590 +3.7% 0% $13,136,529
MILLENNIUM MANAGEMENT LLC 1.5% 3,584,288 -0.97% 0.01% $11,111,293
TWO SIGMA INVESTMENTS, LP 1.5% 3,397,110 +49% 0.02% $10,531,041
Rock Springs Capital Management LP 1.4% 3,266,960 0% 0.52% $10,127,576
PERCEPTIVE ADVISORS LLC 1.3% 3,139,669 -18% 0.18% $9,732,974
Opaleye Management Inc. 1.2% 2,720,000 -0.18% 1.1% $8,432,000
TWO SIGMA ADVISERS, LP 1.1% 2,596,900 +39% 0.02% $8,050,390
JACOBS LEVY EQUITY MANAGEMENT, INC 0.93% 2,178,033 +55% 0.03% $6,751,902
SILVERARC CAPITAL MANAGEMENT, LLC 0.92% 2,135,722 -55% 0.96% $6,620,738
BANK OF AMERICA CORP /DE/ 0.82% 1,906,669 -34% 0% $5,910,674
GOLDMAN SACHS GROUP INC 0.77% 1,792,114 +498% 0% $5,555,554
UBS Group AG 0.76% 1,771,381 -36% 0% $5,491,281

Institutional Holders of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 180,653,789 $559,988,381 +$5,504,913 $3.10 191
2025 Q3 180,099,232 $473,650,742 +$14,481,997 $2.63 162
2025 Q2 177,241,575 $218,003,209 +$9,779,866 $1.23 123
2025 Q1 169,972,743 $186,887,807 -$1,268,144 $1.10 118
2024 Q4 171,313,829 $154,975,691 -$4,643,111 $0.90 102
2024 Q3 174,874,615 $172,644,460 -$19,949,532 $0.99 99
2024 Q2 182,850,284 $164,736,451 -$20,026,799 $0.90 93
2024 Q1 197,765,806 $233,516,476 -$11,193,563 $1.18 105
2023 Q4 203,270,485 $185,471,165 +$4,883,709 $0.91 96
2023 Q3 205,596,440 $171,215,346 +$117,834,337 $0.83 93
2023 Q2 62,010,889 $74,414,154 -$19,164,753 $1.20 94
2023 Q1 77,679,537 $97,875,805 -$40,109,226 $1.26 107
2022 Q4 103,773,723 $225,185,263 -$165,052,760 $2.17 117
2022 Q3 85,232,624 $1,021,045,667 +$262,239,455 $11.98 154
2022 Q2 63,691,207 $533,207,849 +$32,485,845 $8.37 126
2022 Q1 59,875,031 $519,727,258 +$5,179,881 $8.68 138
2021 Q4 58,810,100 $664,847,746 +$43,218,257 $11.31 129
2021 Q3 54,748,025 $687,740,924 +$24,001,097 $12.57 123
2021 Q2 53,088,201 $431,075,177 -$10,198,257 $8.12 109
2021 Q1 54,256,286 $501,857,885 +$8,880,956 $9.25 121
2020 Q4 53,109,159 $513,580,534 -$47,148,476 $9.67 119
2020 Q3 55,543,085 $689,284,591 +$37,297,727 $12.41 122
2020 Q2 52,506,803 $683,821,623 +$177,437,307 $13.00 108
2020 Q1 39,039,096 $396,249,329 -$15,719,655 $10.15 95
2019 Q4 40,415,352 $631,689,853 -$16,734,787 $15.63 86
2019 Q3 41,336,618 $693,682,039 +$153,760,437 $16.79 78
2019 Q2 36,689,307 $812,845,961 +$18,784,299 $22.18 74
2019 Q1 35,897,641 $776,340,000 +$776,340,189 $21.67 71